Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-la... by Incrocci, Luca, Prof, Wortel, Ruud C, MD, Alemayehu, Wendimagegn Ghidey, PhD, Aluwini, Shafak, MD, Schimmel, Erik, MD, Krol, Stijn, MD, van der Toorn, Peter-Paul, MD, Jager, Hanja de, MD, Heemsbergen, Wilma, PhD, Heijmen, Ben, Prof, Pos, Floris, MD

Get full text

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial by Aluwini, Shafak, Dr, Pos, Floris, MD, Schimmel, Erik, MD, van Lin, Emile, MD, Krol, Stijn, MD, van der Toorn, Peter Paul, MD, de Jager, Hanja, MD, Dirkx, Maarten, PhD, Alemayehu, Wendimagegn Ghidey, PhD, Heijmen, Ben, Prof, Incrocci, Luca, MD

Get full text

Adaptive Management of Bladder Cancer Radiotherapy by Pos, Floris, MD, PhD, Remeijer, Peter, PhD

Get full text

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial by Aluwini, Shafak, Dr, Pos, Floris, PhD, Schimmel, Erik, MD, Krol, Stijn, PhD, van der Toorn, Peter Paul, MD, de Jager, Hanja, MD, Alemayehu, Wendimagegn Ghidey, PhD, Heemsbergen, Wilma, PhD, Heijmen, Ben, Prof, Incrocci, Luca, Prof

Get full text